Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChimeriVax-JE vs JE-MBDV in Children
NCT00441259Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Primary completion
- Feb 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Jan 2007; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00441259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441259.